Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
Bristol-Myers Squibb has reached a $10 million settlement to escape claims that it conspired with rivals to keep a blockbuster HIV treatment off the market, and both sides are hoping that...To view the full article, register now.
Already a subscriber? Click here to view full article